Results 141 to 150 of about 14,648,153 (380)

Effectiveness of Pre‐Transplant Dual GLP‐1 Receptor Agonist and SGLT2 Inhibitor Therapy on All‐Cause Mortality in Organ Transplantation Candidates with Obesity and Type 2 Diabetes: a Target‐Trial Emulation

open access: yesAdvanced Science, EarlyView.
This target trial emulation in solid organ transplant candidates with obesity and type 2 diabetes evaluates whether pre‐transplant dual therapy with GLP‐1 receptor agonists plus SGLT2 inhibitors is associated with post‐transplant mortality and kidney graft outcomes compared with monotherapy or usual care, using multinational electronic health records ...
Yu‐Nan Huang   +7 more
wiley   +1 more source

EFFECT OF SENSORINEURAL HEARING LOSS ONTHE TIME-COMPRESSED SPEECH TEST [PDF]

open access: bronze, 2012
Franz Zenker Castro   +5 more
openalex   +1 more source

3D‐Printed Ion‐Conductive Hydrogels with Tunable Mechanical–Electrical Properties for Multimodal Sign Language Recognition

open access: yesAdvanced Science, EarlyView.
This work successfully fabricated ion‐conductive hydrogels with low hysteresis and high conductivity using 3D printing technology. By adjusting the component ratios, the properties of the hydrogels can be tuned to meet diverse sensing requirements. Finally, a multimodal sensing sign language recognition system was constructed based on this hydrogel ...
Quan Hu   +9 more
wiley   +1 more source

Hearing test for Psychogenic Hearing loss

open access: yesAUDIOLOGY JAPAN, 2008
心因性難聴の聴力検査には, 1) 純音オージオメトリー 2) 自記オージオメトリー 3) 他覚的聴力検査の3者が必要である。ただこの中で, 3) の他覚的聴力検査については, 本紙の他の著者の総説の中で詳細に述べられているので, ここでは省略することにした。ここでは1) 純音オージオメトリー 2) 自記オージオメトリーの2者について総説する。心因性難聴では, 純音オージオグラムの“閾値”は真の閾値ではない。しかし“でたらめ”でもなく, 内在する“大きさの感じ (loudness)”によってきめられる。従っていろいろの現象がでたらめではなく, ある傾向によって定められて行く。ここが本症の診断で重要な点である。自記オージオグラムも, 閾値 (きこえる, きこえない) ではなく, ある“大きさ ...
openaire   +2 more sources

Trouble in Toyland: The 26th Annual Survey of Toy Safety [PDF]

open access: yes, 2011
Presents findings on toys that may pose choking hazards, are excessively loud, or contain lead, phthalates, or other toxins. Outlines federal standards and makes recommendations for consumers, policy makers, and the Consumer Product Safety ...

core  

Hearing Loss: From Basic to Clinical Science

open access: yesAdvanced Science, EarlyView.
Abstract Hearing loss (HL) affects over 1.5 billion people globally, with genetic factors accounting for ≈50% of congenital cases. Therefore, HL has become a global health issue, driving extensive research from basic science to clinical applications. This Special Collection includes a total of 31 papers, among which 9 are review papers, 21 are research
Renjie Chai, Hai Huang, Jing Zou
wiley   +1 more source

Compensatory Interplay Between Clarin‐1 and Clarin‐2 Deafness‐Associated Proteins Governs Phenotypic Variability in Hearing

open access: yesAdvanced Science, EarlyView.
Functional compensation between clarin‐1 and clarin‐2 in cochlear hair cells. Hearing loss associated with CLRN1 mutations shows striking phenotypic variability; however, the underlying mechanisms remain poorly understood. This study reveals that clarin‐1 and clarin‐2 function cooperatively in cochlear hair cells to sustain mechanoelectrical ...
Maureen Wentling   +17 more
wiley   +1 more source

Noise induced hearing loss among grass trimming workers [PDF]

open access: yes, 2011
Introduction: Grass trimming workers work every day in a noisy environment as they carry the grass trimming machine on their back, such daily exposure for many years may contribute to noise induced hearing loss. Objective: To assess the hearing status of
Jaafar, Nabeel Ibraheem
core  

Racial and ethnic disparities in diagnostic efficacy of comprehensive genetic testing for sensorineural hearing loss [PDF]

open access: hybrid, 2021
Michelle M. Florentine   +11 more
openalex   +1 more source

Mitochondrial Transplantation as a Therapeutic Strategy for Inherited Mitochondrial Diseases

open access: yesAdvanced Science, EarlyView.
Mitochondrial transplantation (MTx) offers a promising therapeutic avenue for mitochondrial diseases. This review comprehensively evaluates MTx, differentiating its feasibility for mtDNA‐ and nDNA‐based disorders. It examines its potential for genetic correction, alongside inherent limitations, technical challenges, and crucial ethical considerations ...
Parmeshar Singh   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy